Postoperative Radiation Therapy Should Be Used for Completely Resected Stage III-N2 NSCLC in Select Patients

J Thorac Oncol. 2022 Feb;17(2):194-196. doi: 10.1016/j.jtho.2021.08.006.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Carcinoma, Non-Small-Cell Lung* / pathology
  • Humans
  • Lung Neoplasms* / pathology
  • Neoplasm Staging
  • Pneumonectomy